Ogee Clearganics Targeted Blemish Treatment

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The product should be applied directly to active breakouts on the skin. A sufficient amount of the product must be used to ensure complete coverage of the affected area. Gentle pressure should be applied in a massaging motion to help soothe the breakout.

It is recommended to initiate treatment with a small application on an inconspicuous area to assess tolerance. Based on individual response, the frequency of application may be gradually increased to achieve the desired effect.

In the event of a bothersome reaction or undesirable appearance, it is advised to reduce the application frequency to once daily or to discontinue use altogether.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

This product is intended for external use only. It is imperative to avoid contact with the eyes. Individuals with a known sensitivity to Salicylic Acid should refrain from using this product.

When utilizing this product, caution is advised as the concurrent use of other topical acne medications may exacerbate skin dryness or irritation. Should irritation occur, it is recommended to reduce the frequency of application and/or the dosage, and to consider discontinuing use altogether. Additionally, care should be taken to prevent contact with fabrics, as discoloration may occur.

In the event that irritation persists or becomes severe, it is essential to discontinue use and consult a healthcare professional. This product is not to be ingested. It should be stored out of reach of children. In the case of accidental ingestion, immediate medical attention should be sought, and a Poison Control Center should be contacted.

Side Effects

Patients using this product should be aware that it is for external use only and must be kept out of the eyes. Individuals who are sensitive to Salicylic Acid should not use this product. During treatment, the concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin. If irritation occurs, it is recommended to reduce the frequency and/or dose of application, and to consider discontinuing use altogether.

In the event that irritation persists or becomes severe, patients are advised to stop using the product and consult a healthcare professional. Additionally, care should be taken to avoid contact with fabric, as discoloration may occur.

This product should be kept out of reach of children. In the case of ingestion, immediate medical attention should be sought, and contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ogee Clearganics Targeted Blemish Treatment (salicylic acid acne medication). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical attention promptly and contact a Poison Control Center for further guidance.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The product has not been specifically studied in pregnant patients, and there are no explicit statements regarding safety concerns, contraindications, or precautions for use during pregnancy. Additionally, there are no dosage modifications recommended for pregnant individuals. Given the absence of data, healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of overdosage, it is imperative to take immediate action. Ingestion of the product is strictly contraindicated, and it should be kept out of reach of children at all times.

If the product is swallowed, it is crucial to seek medical attention without delay. Healthcare professionals should be contacted, and the local Poison Control Center should be notified to provide specific guidance on management and treatment options.

Prompt intervention is essential to mitigate potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. It is important to emphasize that if the medication is swallowed, patients should seek medical attention immediately and contact a Poison Control Center for further guidance. This precaution is crucial to ensure the safety and well-being of children who may inadvertently access the medication.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product under controlled conditions, avoiding exposure to extreme temperatures, whether hot or cold. Additionally, the product should be kept away from heat sources to maintain its integrity and efficacy. Proper handling and storage are crucial to ensure the product remains effective throughout its shelf life.

Additional Clinical Information

Patients should apply the product directly to active breakouts on the skin, ensuring enough coverage while using gentle pressure in a massaging motion to soothe the area. It is recommended to start with a small application on an inconspicuous area and gradually increase the frequency of use as needed. If any bothersome reactions or changes in appearance occur, patients should reduce the application frequency to once a day or discontinue use altogether.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Ogee Clearganics Targeted Blemish Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)